Advertisements

Blokium Diu

Quick links to important sections

Blokium Diu

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Blokium Diu

Property Description
Active ingredient Atenolol and Chlorthalidone
Form Tablet
Pharmacological class Antihypertensive Agent, Beta-blocker, Diuretic
Common use Management of high blood pressure (Hypertension)
Origin Synthetic

Blokium Diu: Definition and Pharmacological Classification

Blokium Diu is a pharmaceutical product formulated as a fixed-dose combination tablet intended for oral administration. Its fundamental identity is that of an Antihypertensive Agent, a classification used for medications that manage high blood pressure, commonly known as hypertension. The medication is a synthetic compound that utilizes two distinct pharmacological classes—a beta-blocker and a diuretic—to provide complementary physiological effects. This fixed combination has an established role in blood pressure control and therapeutic guidelines.


What Active Ingredients Define Blokium Diu?

The composition is defined by the two principal active ingredients: Atenolol and Chlorthalidone. Atenolol is formally classified as a cardioselective beta-blocker, primarily acting to regulate heart activity. Chlorthalidone, the second component, is a thiazide-like diuretic that facilitates the management of the body's fluid and salt balance. The combination is clinically recognized for offering synergistic blood pressure reduction, which can exceed the results of either component used alone. Combined beta-blocker/diuretic therapies are used for effective blood pressure reduction, as this dual approach provides a strategic option for hypertensive patients.


The General Purpose of this Combination Therapy

The general therapeutic purpose of Blokium Diu is the sustained, long-term management of hypertension in adult patients. By delivering a beta-blocker that reduces the heart's workload and a diuretic that lowers circulating blood volume, the combination is designed to achieve a more comprehensive reduction of blood pressure. This combination therapy is typically implemented for hypertensive patients when achieving satisfactory blood pressure control requires the simultaneous action of a heart rate regulator and a fluid volume reducer, such as in individuals with persistently elevated blood pressure despite prior monotherapy.

Regulatory References

  1. Atenolol on WHO Essential Medicines List (eEML)
  2. Chlorthalidone - NCBI Bookshelf (NIH)
Advertisements

What side effects are possible with Blokium Diu?

Possible Side Effects and Safety Information

The officially documented adverse reactions for this fixed combination (Atenolol and Chlorthalidone) are classified by regulatory authorities based on their reported frequency. These side effects reflect the pharmacological actions on the heart and on fluid balance.

Common Adverse Reactions (affecting 1 to 10 in 100 patients) often involve the cardiovascular and metabolic systems. These include bradycardia (slow heartbeat), fatigue, and cold extremities. Metabolic changes characteristic of the diuretic component are also common, such as hypokalaemia (low potassium), hyponatraemia (low sodium), and hyperuricaemia (high uric acid).

Rare Reactions (affecting less than 1 in 1,000 patients) are documented across several systems, including the nervous system (e.g., dizziness, headache), psychiatric system (e.g., mood changes, hallucinations), and hepatobiliary system (hepatic toxicity, pancreatitis). Rare but clinically significant reactions include the deterioration of heart failure and the precipitation of heart block.

Safety Constraints and Population Considerations

The official labeling notes that some adverse effects may be more frequent at the start of treatment. The combination is absolutely contraindicated in severe pre-existing conditions, including cardiogenic shock, anuria (absence of urine production), and second- or third-degree heart block. Caution is specifically mandated for use in older adults and in patients with impaired renal or hepatic function. Furthermore, there is a risk of severe exacerbation of angina or myocardial infarction associated with the abrupt cessation of therapy in patients with coronary artery disease. The medication may also mask the symptoms of hypoglycemia in patients with diabetes.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

The information in this section is derived strictly from government-approved prescribing documents (e.g., FDA and EMA labeling) and details the manifestations and mandatory actions associated with an overdose of Atenolol and Chlorthalidone.

Documented Manifestations and Severe Outcomes

An overdose is typically associated with an exaggeration of the drug's effects, potentially leading to life-threatening events. Officially documented manifestations include:

Primary Component Risk Documented Manifestations
Atenolol (Cardiovascular) Bradycardia (slow heart rate), Hypotension, Acute Congestive Heart Failure, and Bronchospasm.
Chlorthalidone (Electrolyte) Lethargy, Nausea/Vomiting, Dehydration, and Hypokalemia (low potassium).

Severe outcomes explicitly noted in regulatory documents include Profound Hypotension, Shock, and Coma.

Emergency Actions and Monitoring Requirements

Immediate medical attention is required for any suspected overdose. The official regulatory instruction is to contact a poison control center, emergency room, or physician immediately.

Patients require close hospital supervision and intensive monitoring of vital signs. Supportive measures, such as Gastric Lavage, Activated Charcoal, and specific agents like Atropine (for severe Bradycardia) or IV Fluid Expanders (for Hypotension) are officially described for professional use. Caution with supportive measures is noted for patients with renal failure due to how the body eliminates Atenolol.

Advertisements

Therapeutic Uses of Blokium Diu

What Blokium Diu Treats: Main Uses and Benefits

The purpose of Blokium Diu, a fixed combination of Atenolol and Chlorthalidone, is the focused and sustained therapeutic management of high blood pressure, medically known as Hypertension. The management of blood pressure levels relates to the mitigation of cardiovascular risks. This medication is generally relevant when supportive management for blood pressure is appropriate, particularly when prior management with a single medication has been inadequate.


Sustained Control of Persistent High Blood Pressure

This combination is primarily used to address the chronic and persistent condition of elevated blood pressure in adult patients. The long-term support provided may contribute to easing the overall physiological burden associated with chronic high blood pressure. This approach may assist with maintaining functional stability and offers a therapeutic framework that helps patients manage the systemic strain related to high blood pressure.

Management of Combined Systemic Strain

Blokium Diu is applied in conditions where blood pressure elevation is driven by the dual factors of excessive stress on the heart and systemic fluid imbalance. This combination is applied in addressing issues related to systemic imbalance and heightened physiological activity on the cardiovascular system. This medicine is generally reserved for individuals whose blood pressure remains persistently elevated when treated with single-agent therapy, including in elderly patients who may require therapeutic assistance across two pharmacological domains.

Quick Fact: Relief for Persistent High Blood Pressure
This combination is relevant for managing factors related to systemic imbalance and heightened physiological activity, supporting stability when single treatments are insufficient.
Advertisements

Eligibility and Restrictions for Use

Blokium Diu, a combination of the beta-blocker atenolol and the diuretic chlorthalidone, is primarily prescribed for the management of high blood pressure (hypertension).

It may be used by adults whose blood pressure is not adequately controlled by a single medication. However, certain serious health conditions prevent its safe use, as it may worsen the underlying issue or pose significant risks.


Contraindications (Who Cannot Use Blokium Diu)

This medication should not be used if you have:

  • Known allergy or hypersensitivity to atenolol, chlorthalidone, or other sulfonamide-derived drugs.
  • Severe bradycardia (very slow heart rate).
  • Cardiogenic shock or uncontrolled heart failure.
  • Second- or third-degree heart block (a serious heart rhythm disorder) without a functioning pacemaker.
  • Anuria (inability to produce urine) or severe kidney impairment.
  • Untreated pheochromocytoma (an adrenal gland tumor).
  • Metabolic acidosis.

Precautions (Use with Caution)

Individuals with the following conditions require careful medical assessment and monitoring, as the medication may still be prescribed but with caution and potential dose adjustment:

  • Asthma or other obstructive airways diseases.
  • Diabetes mellitus, as it may mask signs of low blood sugar.
  • Mild to moderate kidney or liver disease.
  • Gout or hyperuricemia (high uric acid levels).
  • Pregnancy or breastfeeding.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines interactions for the fixed-dose combination of Atenolol and Chlorthalidone that are formally documented in official government regulatory labeling, focusing on documented risk, constraints, and required precautions.


Documented Interaction Categories

Interaction Type Interacting Agents / Classes Constraint / Impact
Pharmacodynamic Reinforcement Calcium Channel Blockers (e.g., Verapamil, Diltiazem), Digitalis Glycosides, Antiarrhythmics, Catecholamine-Depleting Drugs Increased risk of severe bradycardia, hypotension, or heart failure. Intravenous administration of Verapamil or Diltiazem is restricted within 48 hours of discontinuing this product.
Altered Clearance & Toxicity Lithium Preparations Chlorthalidone reduces the renal clearance of Lithium, leading to increased serum concentrations and a risk of toxicity. Monitoring is required.
Antagonism of Effect Prostaglandin Synthetase Inhibitors (e.g., Indomethacin), Sympathomimetic Agents May diminish the blood-pressure-lowering effect.
Additive Hypotension Alcohol (Ethanol), Anaesthetic Agents, Clonidine Increased risk of dizziness and orthostatic hypotension. Beta-blocker withdrawal must precede Clonidine withdrawal.

Population-Specific Cautions

Patients treated for diabetes should be monitored, as the Atenolol component can mask the common signs of hypoglycemia (low blood sugar), such as a rapid heart rate. For patients with a history of anaphylactic reactions, the beta-blocker component may reduce responsiveness to usual doses of Epinephrine.

Advertisements

Mechanism of Action

Molecular Targets and Pathway Inhibition

Blokium Diu acts as a modulator of bone cell activity. Its primary mechanism involves the inhibition of the mevalonate pathway in osteoclasts by binding to and inhibiting farnesyl diphosphate synthase (FPPS). This specific inhibition prevents the prenylation of small GTPases, such as Rac and Rho, which are essential for the formation of the osteoclast cytoskeleton and the ruffled border.


Cellular Effects and Cascade

The disruption of the cytoskeleton function subsequently impairs the adhesion and resorptive capacity of the osteoclast cells. This action reduces osteoclast-mediated bone resorption. The compound also interacts with calcium channels on the osteoclast membrane, leading to decreased intracellular calcium flux.


Modulation of Bone Remodeling

Furthermore, the compound promotes the differentiation and activity of osteoblasts, resulting in the modulation of the bone remodeling process through a dual effect on both bone formation and bone breakdown.

Advertisements

Dosage and Administration Information

How Blokium Diu is Used

Blokium Diu is a fixed-dose combination medication for the management of hypertension. The medicine is formulated as a tablet for oral administration only. Standard usage patterns define a once-daily schedule, which is typically part of a long-term treatment plan.

Dosing and Administration

The initial dosage for adult therapy commonly starts with the 50 mg/25 mg strength (Atenolol/Chlorthalidone). If the desired response is not achieved, the maintenance dose may be adjusted upward to the 100 mg/25 mg strength, which represents the maximum recommended daily dose. This medicine can be taken with or without food.

Procedural Instructions and Population Constraints

The usage protocol requires that the dose be managed carefully in patients with reduced kidney function. For individuals with moderate to severe renal impairment (creatinine clearance below 35 mL/min/1.73 m^2), specific dose reductions are indicated to prevent systemic accumulation. For instance, the Atenolol component may be limited to 50 mg every other day in severe impairment. Safety and effectiveness have not been established for pediatric patients.

Due to the beta-blocker component (Atenolol), the administration procedure includes a specific instruction: discontinuation of the medicine must be gradual and should not be done abruptly. If a dose is missed, general guidelines for this combination advise skipping the missed dose if it is almost time for the next scheduled dose, rather than taking a double dose.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of Studies for Blokium Diu

This overview summarizes the scientific evidence for the combination of atenolol (a beta-blocker) and chlorthalidone (a diuretic), based on clinical research and information reviewed by health authorities. It focuses on the types of studies conducted and what the findings indicate, without offering medical advice or treatment instructions.


Evidence for Use in Managing Essential Hypertension

Research has focused primarily on the use of this fixed-dose combination in adults diagnosed with essential hypertension (high blood pressure). Studies conducted included short-term Randomized Controlled Trials (RCTs), where researchers observed responses over defined time intervals, and broader Systematic Reviews that combine data from multiple clinical studies. The evidence is derived from studies that measured short-term or episodic changes in blood pressure.

Types of Studies and Measured Outcomes

Research examined various outcomes related to systemic or functional imbalance associated with high blood pressure. Researchers monitored outcomes by primarily measuring the change in blood pressure readings (systolic and diastolic) from the start to the end of the study period. Studies explored how outcomes evolved in the observed populations by also tracking the percentage of patients who reached specific, pre-set blood pressure goals. Further analysis included observational settings evaluating daily-life functioning, where researchers reported how often patients took their medication as prescribed, known as adherence or persistence.


Comparative Evidence Against Other Treatments

Research explored the difference in measurements when the combination was compared to taking only one of the active ingredients (monotherapy). Studies recorded blood pressure measurements related to the combination for comparison against those taking a single medication. Research also examined this fixed combination against other established combinations of anti-hypertensive drug classes. Furthermore, studies monitored patient adherence, where data show patterns related to patient persistence with a single fixed-dose tablet compared to taking the two components as separate pills.


Long-Term Studies and Durability of Follow-up

Research has monitored patients over varying lengths of time, with studies examining short-term outcomes lasting a few weeks to several months. Longer follow-up durations were limited for this specific fixed combination tablet in large-scale RCTs. Evidence related to outcomes such as the incidence of stroke or heart attack was explored in extensive, long-term studies focusing on the overall drug classes (beta-blockers and diuretics) rather than dedicated, specific trials of this exact fixed combination running for many years.


What Remains Uncertain About the Research

While research has examined blood pressure measurements, certain areas of evidence are still emerging or considered limited. Comparative evidence is limited in the context of recent, large-scale RCTs comparing the atenolol/chlorthalidone fixed combination directly against alternative regimens for long-term cardiovascular outcomes. Sample sizes were modest in some older comparative studies, and evidence quality varies across studies. Therefore, long-term effects are not fully established for this specific fixed combination when directly compared to all modern alternatives.

Key Studies & References Beta-blocker and diuretic fixed-dose combination therapy versus monotherapy for essential hypertension: A systematic review and meta-analysis

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Blokium Diu (FAQ)


Q: How quickly does Blokium Diu start to lower blood pressure?

A: Official information indicates that the beta-blocking effect from the atenolol component begins within about one hour after you take a dose and reaches its maximum effect in 2 to 4 hours. However, the full, steady blood pressure reduction from the combination therapy may take one to two weeks to fully achieve.


Q: What are the most common side effects of Blokium Diu?

A: Common adverse reactions reported with this medicine include slow heart rate (bradycardia), fatigue or lethargy, and cold extremities (hands and feet). Metabolic changes such as high uric acid levels (hyperuricemia) and low potassium levels (hypokalemia) are also frequently reported in regulatory documents.


Q: Can Blokium Diu cause tiredness or fatigue?

A: Yes, tiredness or fatigue is one of the most common adverse reactions officially reported for this combination medication. Some reports indicate that adverse effects may be more frequent at the start of therapy.


Q: Is it normal to feel a bit dizzy when starting Blokium Diu?

A: Dizziness is a documented adverse reaction for this medication. According to official safety information, some adverse effects, like dizziness, may be more frequent when treatment with Blokium Diu is first started.


Q: Does Blokium Diu interact with common over-the-counter pain relievers?

A: Official labeling notes that prostaglandin synthetase inhibitors, which include certain common over-the-counter pain relievers, may reduce the intended blood-pressure-lowering effect of Blokium Diu. Regulatory labeling advises patients to discuss all medicines, including over-the-counter products, with a healthcare provider.


Q: Can Blokium Diu cause changes in mood or sleep?

A: Yes, regulatory documents list both sleep disturbances and mood changes as documented, though uncommon or rare, adverse reactions associated with this medication.


Q: What kind of research has been done on Blokium Diu?

A: Clinical trials, including controlled studies, have been conducted primarily to evaluate the effectiveness of this fixed-dose combination in reducing blood pressure in adult patients diagnosed with hypertension. The evidence is typically derived from measuring changes in blood pressure readings.


Q: Does Blokium Diu help with fluid retention or edema?

A: The medication contains chlorthalidone, a diuretic ('water pill'). The chlorthalidone component helps the body eliminate excess fluid and salt, which contributes to its effect of lowering blood pressure.


Q: Does Blokium Diu cause increased urination?

A: The chlorthalidone component is a diuretic, which works by increasing the excretion of salt and water by the kidneys. This action is generally associated with increased urine production.


Q: Does Blokium Diu affect blood sugar levels?

A: Yes, official warnings note that the medication can affect blood sugar levels. Specifically, the atenolol component may mask or cover up some common signs of low blood sugar, such as a rapid pulse rate, in people with diabetes.


Q: Can Blokium Diu affect potassium levels in the blood?

A: Yes, changes in blood potassium levels are a common adverse metabolic reaction associated with the diuretic component of this medicine. Specifically, low potassium (hypokalemia) is frequently reported in official documentation.


Q: Why does Blokium Diu combine two different types of medicine?

A: Blokium Diu is a fixed-dose combination of a beta-blocker (atenolol) and a diuretic (chlorthalidone). Official information states the combination is used to treat high blood pressure because the effects of the two components on lowering blood pressure are approximately additive.


Q: What happens if I miss a dose of Blokium Diu?

A: Official regulatory instructions for a missed dose advise skipping it if it is almost time for the next scheduled dose, rather than taking a double dose. Specific dose management guidance is found in the prescribing information.


Q: What research supports the use of Blokium Diu for its main indications?

A: The use of Blokium Diu for treating high blood pressure is supported by clinical studies and is stated in the 'Indications and Usage' section of the official product labeling.


Q: Is there a generic version of Blokium Diu available?

A: Yes, the fixed-dose combination of the active ingredients, atenolol and chlorthalidone, is available as a generic medication.


Q: Can I take multivitamins with Blokium Diu?

A: The labeling advises patients to tell their healthcare provider about all current medicines, including prescription and over-the-counter medicines, vitamins, and herbal products, as drug interactions are possible.


Q: What are the signs that Blokium Diu is working?

A: The primary goal of this medication is a measured reduction in blood pressure. Since high blood pressure often does not cause noticeable symptoms, the drug's effectiveness is verified through monitoring blood pressure readings.


Q: Do I need to change my diet while taking Blokium Diu?

A: Regulatory labeling instructs patients to follow all directions given by their prescribing healthcare provider. The diuretic component may necessitate monitoring of fluid and electrolyte levels, but no specific dietary changes are universally mandated in the core label.


Q: Is it okay to stop taking Blokium Diu suddenly?

A: No, sudden discontinuation of this medicine is not recommended, particularly in patients with pre-existing coronary artery disease. Stopping abruptly may lead to worsening chest pain (angina) or, in rare cases, a heart attack.


Q: What is the expected duration of treatment with Blokium Diu?

A: Blokium Diu is indicated for the treatment of hypertension (high blood pressure). Since hypertension is a chronic condition, treatment with this medicine usually requires continued, long-term use.


Q: Can Blokium Diu interact with natural supplements like St. John's Wort?

A: The official guidance advises that all medicines, including herbal products and supplements like St. John's Wort, be discussed with a healthcare provider, as potential drug interactions are a possibility.


Q: Is Blokium Diu used with caution in people with liver conditions?

A: Caution is specifically mandated in official labeling for use in patients with impaired hepatic (liver) function. Official warnings also note that severe, rare adverse reactions can include hepatic toxicity.


Q: Do you gain or lose weight when taking Blokium Diu?

A: While weight change is not listed as a common side effect, regulatory warnings note that rapid weight gain and swelling are listed as a serious side effect that requires immediate medical attention.


Q: Can Blokium Diu cause muscle cramps or weakness?

A: Yes, the diuretic component can affect electrolyte balance. Muscle pain, cramps, or unusual weakness can be signs of low potassium levels (hypokalemia), which is a commonly reported metabolic side effect of this medicine.


Q: Can Blokium Diu interact with common herbal teas?

A: Regulatory guidance includes advising patients to inform their healthcare provider about all current medicines, including herbal products and teas, as drug interactions are possible and not all potential interactions are documented.


Q: Is Blokium Diu used for purposes other than high blood pressure?

A: According to the official product labeling, Blokium Diu is indicated solely for the treatment of essential hypertension (high blood pressure).

Advertisements

How should Blokium Diu be stored and disposed of?

Storage Requirements

Blokium Diu tablets must be stored at controlled room temperature, typically defined as 20 C to 25 C (68 F to 77 F), with excursions permitted up to 30 C (86 F). The product must be protected from light and moisture and should not be stored in high-humidity areas, such as a bathroom.

It is required to keep the medicine in the original container, ensure the container is tightly closed, and do not freeze the tablets. Stability is maintained up to the expiry date when stored according to these labeled conditions.

Child Safety and Disposal

For safety, the medication must be stored out of the sight and reach of children and pets at all times. When discarding unused or expired Blokium Diu, regulatory guidance advises against flushing tablets down the toilet or placing them in household trash.

Disposal should be managed through an official method, such as a drug take-back program or by consulting a pharmacist or local waste disposal service for instruction.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Blokium Diu found in:

A-Z Index: